Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
AXSM
Stock Latest News
Weekend Updates
Aptiv, IIPR, Huntington, PNC, Axsome Trending by Analysts
14d ago
PNC
APTV
Premium
The Fly
Axsome Therapeutics assumed with an Overweight at Morgan Stanley
16d ago
AXSM
Premium
Ratings
Positive Outlook for Axsome Therapeutics Driven by Regulatory Progress and Commercial Success
16d ago
AXSM
Premium
The Fly
Axsome Therapeutics participates in Alzheimer’s, Brain Health Awareness Month
29d ago
AXSM
Premium
Ratings
Optimistic Buy Rating for Axsome Therapeutics Amid Promising Developments and Strategic Initiatives
29d ago
AXSM
Premium
The Fly
Axsome Therapeutics supports Migraine, Headache Awareness Month
1M ago
AXSM
Premium
Ratings
Strong Growth Potential and Market Penetration Drive Buy Rating for Axsome Therapeutics
1M ago
AXSM
Premium
The Fly
Axsome Therapeutics price target lowered to $186 from $193 at RBC Capital
1M ago
AXSM
Premium
Ratings
Axsome Therapeutics: Buy Rating Affirmed Amid Promising Pipeline Developments and Strategic Focus
1M ago
AXSM
Premium
Company Announcements
Axsome Therapeutics Launches SYMBRAVO for Migraine Relief
1M ago
8K
AXSM
Premium
The Fly
Axsome Therapeutics announces availability of SYMBRAVO in U.S.
1M ago
AXSM
Premium
Ratings
Positive Outlook for Axsome Therapeutics Despite Regulatory Setback, Driven by Promising Pipeline and Market Potential
1M ago
AXSM
Premium
Ratings
Axsome Therapeutics: Overcoming AXS-14 Setback with Strategic Focus on AXS-05
1M ago
AXSM
Premium
Company Announcements
Axsome Therapeutics Shareholders Approve Key Proposals at Meeting
1M ago
8K
AXSM
Premium
The Fly
Axsome’s AXS-14 gets regulatory setback with RTF, says Morgan Stanley
1M ago
AXSM
Premium
Ratings
Axsome Therapeutics’ Growth Prospects Remain Strong Despite FDA Setback on AXS-14
1M ago
AXSM
Premium
Ratings
Axsome Therapeutics’ Strategic Response to FDA Feedback Supports Buy Rating
1M ago
AXSM
Premium
Company Announcements
FDA Refuses Axsome’s NDA for Fibromyalgia Drug
1M ago
8K
AXSM
Premium
The Fly
Axsome Therapeutics receives RTF letter from FDA for AXS-14 NDA
1M ago
AXSM
Premium
Ratings
Axsome Therapeutics: A Promising Growth Stock with Robust Pipeline and Strong Financials
2M ago
AXSM
Premium
The Fly
Axsome Therapeutics initiated with an Outperform at Oppenheimer
2M ago
AXSM
Premium
Ratings
Strategic Settlements and Market Opportunities Bolster Axsome Therapeutics’ Buy Rating
2M ago
AXSM
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
